Respiri logo

RSH - Respiri Share Price

A$0.091 0.0  9.6%

Last Trade - 3:44am

Sector
Healthcare
Size
Micro Cap
Market Cap £23.0m
Enterprise Value £23.3m
Revenue £543k
Position in Universe 919th / 1836
Bullish
Bearish
Unlock RSH Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

RSH Revenue Unlock RSH Revenue

Net Income

RSH Net Income Unlock RSH Revenue

Normalised EPS

RSH Normalised EPS Unlock RSH Revenue

PE Ratio Range

RSH PE Ratio Range Unlock RSH Revenue

Dividend Yield Range

RSH Dividend Yield Range Unlock RSH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
RSH EPS Forecasts Unlock RSH Revenue
Profile Summary

Respiri Limited, formerly Isonea Limited, is engaged in the research, development and commercialization of medical devices, and the production of mobile health applications. The Company's segments include Australia and Israel. The Australia segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Israel. The Company's devices and applications use digital wheeze detection and measurement technology. The Company's acoustic respiratory monitoring (ARM) technology records airway sounds to detect continuous adventitious breath sounds (CABS), and measures the extent of wheezing caused by airway obstruction. The Company's products include AirSonea, SonoSentry, Wholter and PulmoTrack Computerised Wheeze Detection.

Directors
Last Annual June 30th, 2019
Last Interim June 30th, 2019
Incorporated May 7, 1987
Public Since July 14, 2000
No. of Shareholders: n/a
No. of Employees: 2
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 525,883,098
Free Float (0.0%)
Eligible for
ISAs
SIPPs
RSH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for RSH
Upcoming Events for RSH
Similar to RSH
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.